Table 2.
Vestibular neuritis.
Study | Study Type | n | Both Tests | Caloric Test | vHIT | |||||
---|---|---|---|---|---|---|---|---|---|---|
Both Normal | Both Abnormal | Dissociation | n Dissoc/n Total | Abnormality Definition (Unilateral Weakness) | Abnormal | Abnormality Definition (Unilateral Weakness) | Abnormal (Hor SCC) | |||
Hannigan et al. 2021 [34] | Retrospective | 31 | 0 | 26 | 5 | 5/31 | CP ≥ 30% | 31 | gain < 0.8 | 26 |
Mekki et al. 2021 [48] | Prospective | 24 | 5 | 6 | 13 | 13/24 | CP ≥ 20% | 18 | gain < 0.8 or gain asymmetry > 8% | 7 |
Kitano et al. 2020 [33] | Prospective | 10 | 8 | 0 | 2 | 2/10 | SPV response < 10°/s | 2 | gain < 0.8 | 0 |
Shugyo et al. 2020 [35] | Prospective | 11 | 1 | 9 | 1 | 1/11 | SPV < 20°/s | 9 | gain < 0.8 | 10 |
Jung et al. 2017 [32] | Retrospective | 19 | 0 | 18 | 1 | 1/19 | CP ≥ 25% | 19 | gain < 0.8 with corrective saccade | 18 |
Bartolomeo et al. 2014 [47] | Prospective | 29 | Acute: | 10/58 | CP >30% | Acute: 29 | gain < 0.8 | Acute: 26 | ||
0 | 26 | 3 | ||||||||
Follow-up: | Follow-up: 20 | Follow-up: 13 | ||||||||
9 | 13 | 7 | ||||||||
Mahringer & Rambold 2014 [30] | Retrospective | 29 | Acute: | 13/59 | CP ≥ 25% | Acute: 29 | gain < 0.8 | Acute: 26 | ||
0 | 26 | 3 | ||||||||
30 | Non-acute: | Non-acute: 30 | Non-acute: 20 | |||||||
0 | 20 | 10 | ||||||||
Summary |
21.2%
(45/212) |
CP: caloric paresis, SPV: slow phase velocity.